^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    Ribonucleotide reductase inhibitor

    Related drugs:
    Apply
    Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors (ETCTN 10388) (NCT04234568)
    Phase 1
    National Cancer Institute (NCI)
    Active, not recruiting
    Last update posted :
    06/13/2024
    Initiation :
    07/20/2020
    Primary completion :
    12/01/2024
    Completion :
    12/01/2024
    SSTR
    |
    SSTR Expression
    |
    Lutathera (lutetium Lu 177 dotatate) • Triapine (3-AP)
    Role of BMP Pathway in MDS Progression (BMP-MDS) (NCT06175923)
    Phase N/A
    Hospices Civils de Lyon
    Not yet recruiting
    Last update posted :
    01/23/2024
    Initiation :
    01/27/2024
    Primary completion :
    01/27/2029
    Completion :
    01/27/2034
    BMP2 • BMP4
    |
    azacitidine • hydroxyurea
    Randomized Phase III Study of Decitabine +/- Hydroxyurea (HY) Versus HY in Advanced Proliferative CMML (GFM-DAC-CMML) (NCT02214407)
    Phase 3
    Groupe Francophone des Myelodysplasies
    Completed
    Last update posted :
    11/19/2021
    Initiation :
    10/14/2014
    Primary completion :
    07/05/2021
    Completion :
    08/16/2021
    ABL1 • BCR
    |
    decitabine • hydroxyurea
    MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer (NCT00003736)
    Phase N/A
    Abramson Cancer Center of the University of Pen...
    Completed
    Last update posted :
    09/24/2019
    Initiation :
    06/01/1999
    Primary completion :
    06/01/2002
    Completion :
    06/01/2002
    BRCA1 • BRCA2
    |
    BRCA2 mutation • BRCA1 mutation
    |
    Xcytrin (motexafin gadolinum)
    A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer (NCT00637247)
    Phase 2
    AmpliMed Corporation
    Completed
    Last update posted :
    03/20/2019
    Initiation :
    04/01/2008
    Primary completion :
    05/01/2010
    Completion :
    06/01/2010
    G6PD
    |
    gemcitabine • Amplimexon (imexon)
    Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia (FAST) (NCT02611973)
    Phase 3
    Assistance Publique - Hôpitaux de Paris
    Recruiting
    Last update posted :
    07/26/2017
    Initiation :
    03/10/2016
    Primary completion :
    11/01/2019
    Completion :
    11/01/2022
    JAK2 • CALR
    |
    JAK2 V617F • CALR mutation
    |
    hydroxyurea • aspirin
    Primary Thrombocythaemia 1 Trial (NCT00175838)
    Phase N/A
    University of Cambridge
    Completed
    Last update posted :
    01/18/2017
    Initiation :
    07/01/1997
    Primary completion :
    11/01/2016
    Completion :
    11/01/2016
    ABL1 • BCR
    |
    hydroxyurea • aspirin
    Imexon for Relapsed Follicular and Aggressive Lymphomas (NCT01314014)
    Phase 2
    University of Rochester
    Completed
    Last update posted :
    01/06/2016
    Initiation :
    05/01/2011
    Primary completion :
    03/01/2013
    Completion :
    08/01/2014
    G6PD
    |
    Amplimexon (imexon)
    Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004) (NCT02480608)
    Phase 1/2
    University of Leipzig
    Completed
    Last update posted :
    06/24/2015
    Initiation :
    04/01/2004
    Primary completion :
    08/01/2011
    Completion :
    05/01/2013
    ABL1 • BCR
    |
    imatinib • hydroxyurea